20/20 Biolabs Analyst Price Targets - Benzinga

20/20 Biolabs Inc

AIDXNASDAQ

Trade with Public

Trade with Public

$0.1867

-0.0422-18.44%

最終更新: Nov 5, 7:22 PM

概要ニュース業績予想イベント目標株価財務センチメント比較株式レポート

20/20 Biolabs Analyst Price Targets

Wall Street analyst price targets and consensus rating for 20/20 Biolabs (AIDX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$5Upside to Avg. PT+2575.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 11, 2026	Maxim Group	Michael Okunewitch	Initiate	Buy	$5

Analyst Ratings News

PRO
Maxim Group Initiates Coverage On 20/20 Biolabs with Buy Rating, Announces Price Target of $5

Maxim Group analyst Michael Okunewitch initiates coverage on 20/20 Biolabs (NASDAQ:AIDX) with a Buy rating and announces Price Target of $5.

Benzinga Newsdesk